Antithrombotic Therapy, Anticoagulation Management, and Vascular Protection: A Triad in the Making
Target Audience
Learning Objectives
- Have increased knowledge regarding the
- Mechanism of action of factor Xa inhibitors in the coagulation cascade
- Clinical efficacy and safety of factor Xa inhibitors across the continuum of anticoagulation management
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
Moderator
Christan T. Ruff, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Director of General Cardiology
Brigham and Women's Hospital
Boston, Massachusetts
Course Reviewer
Matthew Sorrentino, MD, FACC, FAHA
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Physician Credit
Nurse and Other Healthcare Professions Credit
Click here to view the activity or if you are logged in click on the "Complete Activity" button!